Bioceres Crop Solutions Corp. (BCBA:BIOX)
Argentina flag Argentina · Delayed Price · Currency is ARS
5,920.00
0.00 (0.00%)
At close: May 30, 2025, 5:00 PM BRT

Bioceres Crop Solutions Statistics

Total Valuation

BCBA:BIOX has a market cap or net worth of ARS 367.39 billion. The enterprise value is 717.01 billion.

Market Cap 367.39B
Enterprise Value 717.01B

Important Dates

The last earnings date was Monday, May 12, 2025.

Earnings Date May 12, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -4.74%
Shares Change (QoQ) -0.59%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 32.63M

Valuation Ratios

PE Ratio n/a
Forward PE 39.94
PS Ratio 0.89
PB Ratio 0.99
P/TBV Ratio 16.23
P/FCF Ratio 8.75
P/OCF Ratio 7.39
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.47, with an EV/FCF ratio of 17.09.

EV / Earnings -73.78
EV / Sales 1.56
EV / EBITDA 13.47
EV / EBIT 28.62
EV / FCF 17.09

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.82
Debt / EBITDA 6.23
Debt / FCF 7.30
Interest Coverage 0.88

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 2.27%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -60.47% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -60.47%
50-Day Moving Average 5,452.20
200-Day Moving Average 7,903.18
Relative Strength Index (RSI) 60.54
Average Volume (20 Days) 35,972

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 4.30

Income Statement

In the last 12 months, BCBA:BIOX had revenue of ARS 411.31 billion and -9.72 billion in losses. Loss per share was -154.77.

Revenue 411.31B
Gross Profit 161.29B
Operating Income 24.05B
Pretax Income -20.14B
Net Income -9.72B
EBITDA 44.08B
EBIT 24.05B
Loss Per Share -154.77
Full Income Statement

Balance Sheet

The company has 33.48 billion in cash and 306.52 billion in debt, giving a net cash position of -273.05 billion.

Cash & Cash Equivalents 33.48B
Total Debt 306.52B
Net Cash -273.05B
Net Cash Per Share n/a
Equity (Book Value) 371.65B
Book Value Per Share 5,297.02
Working Capital n/a
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 49.75 billion and capital expenditures -7.78 billion, giving a free cash flow of 41.96 billion.

Operating Cash Flow 49.75B
Capital Expenditures -7.78B
Free Cash Flow 41.96B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 39.21%, with operating and profit margins of 5.85% and -2.36%.

Gross Margin 39.21%
Operating Margin 5.85%
Pretax Margin -4.90%
Profit Margin -2.36%
EBITDA Margin 10.72%
EBIT Margin 5.85%
FCF Margin 10.20%

Dividends & Yields

BCBA:BIOX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 4.74%
Shareholder Yield n/a
Earnings Yield -2.65%
FCF Yield 11.42%

Stock Splits

The last stock split was on January 24, 2024. It was a forward split with a ratio of 2.

Last Split Date Jan 24, 2024
Split Type Forward
Split Ratio 2

Scores

Altman Z-Score n/a
Piotroski F-Score n/a